New research refutes the theory that cannabis is a ‘gateway drug’.
Researchers found no significant increase in the rates of psychosis-related diagnoses in states which have introduced legalisation.
Researchers found a reduction of 26% in pharmacy-based distribution of codeine in states where cannabis was legal.
New studies highlight the effects of cannabis in those living with depression, childhood epilepsy and inflammatory bowel disease (IBD).
New studies explore cannabis for sleep, muscle recovery, CUD, MS and IBD.
The findings have led to calls for more patient-doctor communication around its use in medical care.
Three new studies from the US and Canada explore different angles to the complex relationship between cannabis use and pregnancy.
The findings help us understand the therapeutic effects of THC at the molecular level.
More than 4,300 cannabis studies were published worldwide in the last 12 months.
Cannabinoids were shown to reduce toxicity in the liver caused by ethanol.
